TY  - GEN
AU  - Fox,Elizabeth
AU  - Mosse',Yael P
AU  - Meany,Holly M
AU  - Gurney,James G
AU  - Khanna,Geetika
AU  - Jackson,Hollie A
AU  - Gordon,Gary
AU  - Shusterman,Suzanne
AU  - Park,Julie R
AU  - Cohn,Susan L
AU  - Adamson,Peter C
AU  - London,Wendy B
AU  - Maris,John M
AU  - Balis,Frank M
TI  - Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621)
SN  - 1545-5017
PY  - 2014///0604
KW  - Adolescent
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Biomarkers
KW  - Capsules
KW  - Child
KW  - Child, Preschool
KW  - Combined Modality Therapy
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Gastrointestinal Diseases
KW  - chemically induced
KW  - Hematologic Diseases
KW  - Humans
KW  - Male
KW  - Nervous System Diseases
KW  - Neuroblastoma
KW  - drug therapy
KW  - Quality of Life
KW  - Recurrence
KW  - Salvage Therapy
KW  - Sulfonamides
KW  - Suspensions
KW  - Treatment Failure
KW  - Tubulin Modulators
KW  - therapeutic use
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/pbc.24900
ER  -